A 36 year old woman ruptured her right Achilles tendon in a skiing accident. Previous medical history is unremarkable except for a history of migraine for many years. She is married with three children with no history of spontaneous miscarriage. She smokes 15 cigarettes a day and takes the oral contraceptive pill.
She is admitted to a local hospital where surgery to repair the Achilles tendon is performed followed by fitting of a plaster cast. Due to pain from the plaster cast she is slow to mobilise. On day 7 postoperatively she develops increasing pain in the right leg. When the plaster is removed the right calf is found to be painful, warm, and swollen. The next day while straining on the toilet she collapsed with left arm weakness. Clinical examination revealed dysarthria with pyramidal weakness of the left arm.
The significance of these symptoms, the diagnosis, and the short and long term treatment of these postoperative problems are discussed in an interactive case presentation.
Learning objectives
When you have completed this case you should understand:
The importance of screening for thrombophilia in a patient with unexplained thromboembolism
The association between PFO, atrial septal aneurysm and cryptogenic stroke
The clinical diagnosis of PFO
The clinical syndromes associated with PFO
Controversies in the management of patients with PFO and cryptogenic stroke: medical versus surgical versus percutaneous device closure.
References
- 1.Lamy C, Giannesini C, Zuber M, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA study. Atrial septal aneurysm. Stroke 2002;33:706–11. [DOI] [PubMed] [Google Scholar]
- 2.Mas J-, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740–6. [DOI] [PubMed] [Google Scholar]
- 3.Kerut EK, Norfleet W, Plotnick GD, et al. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol 2001;38:613–23. [DOI] [PubMed] [Google Scholar]
- 4.Cheng TO. Platypnea-orthodeoxia syndrome: etiology, differential diagnosis, and management. Catheter Cardiovasc Interven 1999;47:64–6. [DOI] [PubMed] [Google Scholar]
- 5.Alp N, Clarke N, Banning AP. How should patients with patent foramen ovale be managed? Heart 2001;85:242–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Homma S, Sacco RL, Di Tullio MR, et al. Effect of medical treatment in stroke patients with patent foramen ovale. Circulation 2002;105:2625–31. [DOI] [PubMed] [Google Scholar]
- 7.Dearani JA, Ugurlu BS, Danielson GK, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular events. Circulation 1999;100(suppl II): II-171–5. [DOI] [PubMed] [Google Scholar]
- 8.Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism. Long-term risk of recurrent thromboembolic events. Circulation 2000;101:893–8. [DOI] [PubMed] [Google Scholar]
- 9.Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomized trials. Lancet 2001;358:9–15. [DOI] [PubMed] [Google Scholar]
- 10.Kock HJ, Scmit-Neuburg KP, Hanke J, et al. Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilization of the leg. Lancet 1995;346:459–61. [DOI] [PubMed] [Google Scholar]
- 11.Lassen MR, Borris LC, Nakov RL. Use of the low-molecular weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization. N Engl J Med 2002;347:726–30. [DOI] [PubMed] [Google Scholar]
- 12.Joffe HV, Goldhaber SZ. Laboratory thrombophilias and venous thromboembolism. Vasc Med 2002;7:93–102. [DOI] [PubMed] [Google Scholar]
- 13.Guba SC, Fonseca V, Fink LM. Hyperhomocysteinemia and thrombosis. Semin Thromb Hemost 1999;25:291–309. [DOI] [PubMed] [Google Scholar]
- 14.Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;347:752–63. [DOI] [PubMed] [Google Scholar]
- 15.Meade TW. Thrombosis and cardiovascular disease. Ann Epidemiol 1992;2:353–64. [DOI] [PubMed] [Google Scholar]
- 16.Milhaud D, Bogousslavsky J, van Melle G, et al. Ischemic stroke and active migraine. Neurology 2001;57:1805–11. [DOI] [PubMed] [Google Scholar]
- 17.Reul J, Weis J, Jung A, et al. Central nervous system lesions and cervical disc herniations in amateur divers. Lancet 1995;345:1403–5. [DOI] [PubMed] [Google Scholar]
- 18.Knauth M, Ries S, Pohimann S, et al. Cohort study of multiple brain lesions in sport divers: role of a patent foramen ovale. BMJ 1997;314:701–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 2003;107:5–9. [DOI] [PubMed] [Google Scholar]
- 20.Rome JJ, Keane JF, Perry SB, et al. Double-umbrella closure of atrial septal defects. Initial clinical applications. Circulation 1990;82:751–8. [DOI] [PubMed] [Google Scholar]
- 21.Krumsdorf U, Keppeler P, Horvath K, et al. Catheter closure of atrial septal defects and patent foramen ovale in patients with an atrial septal aneurysm using different devices. J Interv Cardiol 2001;14:49–55. [DOI] [PubMed] [Google Scholar]